Clinical Trial: The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A One-Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Brief Summary: To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.

Detailed Summary:
Sponsor: Eisai Inc.

Current Primary Outcome: Assessment of cognitive and global function in subjects with MCI.

Original Primary Outcome: Same as current

Current Secondary Outcome: Behavioral, global and cognitive outcomes; Neuroimaging

Original Secondary Outcome: Same as current

Information By: Eisai Inc.

Dates:
Date Received: February 16, 2006
Date Started: December 2003
Date Completion:
Last Updated: March 31, 2011
Last Verified: March 2011